Fred J. Roisen

Corporate Officer/Principal at University of Louisville

Consumer Services

Health Technology

Profile

Fred J.
Roisen is the founder of RhinoCyte, Inc. which was founded in 2005.
He held the title of President & Chief Executive Officer from 2009 to 2013.
Currently, he is a Professor at the University of Louisville since 1986.
Dr. Roisen has an undergraduate degree from Northeastern University and graduate and doctorate degrees from Princeton University.

Fred J. Roisen active positions

Companies	Position	Start
University of Louisville	Corporate Officer/Principal	1985-12-31

All active positions of Fred J. Roisen

Former positions of Fred J. Roisen

Companies	Position	End
RhinoCyte, Inc. RhinoCyte, Inc. Medical SpecialtiesHealth Technology RhinoCyte, Inc. develops and commercializes diagnostic tools and therapies. The firm engages in the discovery and development of products to extend and enhance the quality of human life. Its technology facilitates functional recovery in patients, including therapeutic stem cell transplantation with cells from the patient's own nasal cavity eliminating the need for immunosuppressive therapy. The company was founded by Fred J. Roisen and Steven R. Gailar in 2005 and is headquartered in Louisville, KY.	Founder	-

See the detail of Fred J. Roisen's experience

Training of Fred J. Roisen

Princeton University	Doctorate Degree
Northeastern University	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Fred J. Roisen's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
RhinoCyte, Inc. RhinoCyte, Inc. Medical SpecialtiesHealth Technology RhinoCyte, Inc. develops and commercializes diagnostic tools and therapies. The firm engages in the discovery and development of products to extend and enhance the quality of human life. Its technology facilitates functional recovery in patients, including therapeutic stem cell transplantation with cells from the patient's own nasal cavity eliminating the need for immunosuppressive therapy. The company was founded by Fred J. Roisen and Steven R. Gailar in 2005 and is headquartered in Louisville, KY.	Health Technology